Boehringer Ingelheim Canada

For Boehringer Ingelheim Canada, import alert is 68-19; import alert name is "DETENTION WITHOUT PHYSICAL EXAMINATION OF UNAPPROVED FINISHED NEW ANIMAL DRUGS"; country is CANADA; address is 5180 South Service Rd , Burlington, Ontario CANADA; date published is 09/06/2024, verified against its source on 2026-08-06.

Firm: Boehringer Ingelheim Canada verified
Import alert: 68-19 verified
Import alert name: "DETENTION WITHOUT PHYSICAL EXAMINATION OF UNAPPROVED FINISHED NEW ANIMAL DRUGS" verified
Country: CANADA verified
Address: 5180 South Service Rd , Burlington, Ontario CANADA verified
Date published: 09/06/2024 verified
Product code: 60 L - - 99 Analgesic, N.E.C. | 65 V - - 99 Sedative N.E.C. verified
Product: Sedivet (Romifidine hydrochloride) | Sedivet (Romifidine hydrochloride) verified

Sourceaccessdata.fda.gov

Verified2026-08-06

Review by2026-10-05

DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Boehringer Ingelheim Canada Date Published : 09/06/2024 5180 South Service Rd , Burlington, Ontario CANADA 60 L - - 99 Analgesic, N.E.C. Date Published: 09/06/2024 Desc: Sedivet (Romifidine hydrochloride) 65 V - - 99 Sedative N.E.C. Date Published: 09/06/2024 Desc: Sedivet (Romifidine hydrochloride)

— accessdata.fda.gov, retrieved 2026-08-06

Source

accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1147.html

Last verified against source: 2026-08-06. Due for re-check by 2026-10-05. This page as Markdown · OKF bundle · full dataset as JSON.